The emergence of phox-ER stress induced immunogenic apoptosis

OncoImmunology

Volumn 1, Issue 5, 2012, Pages 786-788

  Garg, Abhishek D ^a   Krysko, Dmitri V ^b,c   Vandenabeele, Peter ^b,c   Agostinis, Patrizia ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

ATP; Calreticulin; Immunogenic apoptosis; Photodynamic therapy; Phox ER stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALRETICULIN; CASPASE 8; DOXORUBICIN; HYPERICIN; INITIATION FACTOR 2ALPHA; MITOXANTRONE; OXALIPLATIN; PERK PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELLULAR SECRETION; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; HUMAN; IMMUNOGENIC APOPTOSIS; IMMUNOGENICITY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOOXIDATION; PRIORITY JOURNAL; TUMOR IMMUNITY;

EID: 84866904950     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19750     Document Type: Article

References (10)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID: 21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
2. Galluzzi L, Kepp O, Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J 2012; 31:1062-79; PMID: 22252132; http://dx.doi.org/10.1038/emboj.2012.2
3. Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 2010; 1805:53-71; PMID: 19720113
4. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.org/10.1038/nm1523
5. Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012; 31: 1055-7; PMID:22252128; http://dx.doi.org/10.1038/emboj.2011.497
6. Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004; 3:294-300; PMID:15523100; http://dx.doi.org/10.1177/1534735404270335
7. Vergely C, Delemasure S, Cottin Y, Rochette L. Preventing the cardiotoxic effects of anthracyclines: from basic concepts to clinical data. Heart Metab 2007; 35:1-7.
8. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Photochem Photobiol Sci 2011; 10:670-80; PMID:21258717; http://dx.doi.org/10.1039/c0pp00294a
9. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother 2012; 61:215-21; PMID:22193987; http://dx.doi.org/10.1007/s00262-011-1184-2
10. Sanovic R, Verwanger T, Hartl A, Krammer B. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma. Photodiagnosis Photodyn Ther 2011; 8:291-6; PMID: 22122915; http://dx.doi.org/10.1016/j.pdpdt.2011.04.003